검색
Radiopharm Theranostics Ltd
RADX관심 목록에 추가
3.080USD
-0.120-3.75%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Radiopharm Theranostics Ltd 회사
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.
Radiopharm Theranostics Ltd 정보
종목 코드 RADX
회사 이름Radiopharm Theranostics Ltd
상장일Nov 25, 2021
CEOCanevari (Riccardo)
직원 수- -
유형Depository Receipt
회계 연도 종료- -
주소Level 3, 62 Lygon Street
도시MELBOURNE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Australia
우편 번호3053
전화61398245254
웹사이트https://radiopharmtheranostics.com/
종목 코드 RADX
상장일Nov 25, 2021
CEOCanevari (Riccardo)
Radiopharm Theranostics Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Riccardo Canevari
Mr. Riccardo Canevari
Chief Executive Officer, Managing Director
Chief Executive Officer, Managing Director
--
--
Mr. Paul Hopper
Mr. Paul Hopper
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Thomas H. (Thom) Tulip, Ph.D.
Dr. Thomas H. (Thom) Tulip, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Dimitris Voliotis, M.D.
Dr. Dimitris Voliotis, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Hester Larkin
Ms. Hester Larkin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ian Turner
Mr. Ian Turner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phillip Hains
Mr. Phillip Hains
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Noel P. Donnelly
Mr. Noel P. Donnelly
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Bruce Goodwin
Mr. Bruce Goodwin
Non-Executive Director
Non-Executive Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Riccardo Canevari
Mr. Riccardo Canevari
Chief Executive Officer, Managing Director
Chief Executive Officer, Managing Director
--
--
Mr. Paul Hopper
Mr. Paul Hopper
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Thomas H. (Thom) Tulip, Ph.D.
Dr. Thomas H. (Thom) Tulip, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Dimitris Voliotis, M.D.
Dr. Dimitris Voliotis, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Hester Larkin
Ms. Hester Larkin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ian Turner
Mr. Ian Turner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
자주 묻는 질문
Radiopharm Theranostics Ltd의 상위 5대 주주는 누구인가요?
Radiopharm Theranostics Ltd의 상위 5대 주주는 다음과 같습니다: Mr. Riccardo Canevari
Radiopharm Theranostics Ltd(RADX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Radiopharm Theranostics Ltd의 주식을 보유한 기관은 총 11곳이며, 이들이 보유한 주식의 총 가치는 약 51.39M로 전체 발행 주식의 3.30%를 차지합니다. 이는 2025Q4 대비 50862187.00 증가한 수치입니다.